IS Pharma introduces Isoplex in UK
According to the company, Isoplex will be used in situations where a patient is losing blood, such as trauma or surgery, and there is a need to increase
Ionis Pharmaceuticals has entered a licence agreement granting global pharmaceutical company Recordati exclusive rights to develop and commercialise zilganersen to treat Alexander disease (AxD) in countries outside the US.